Sign in

CIK 0001314102

  • Non-accelerated filer
  • Smaller reporting company

EyePoint, Inc.

Sign in to watch
Ticker
EYPT
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
262774444
Phone
+1 617-926-5000
Business address
480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
Former names
EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
  1. 4 Open-market buy Director bought 12,500 shares at $7.98 ($99,750)
  2. 4 Open-market buy Director bought 3,173 shares at $7.88 ($25,003)
  3. 4 Derivatives Options or other derivatives
  4. 4 Planned sale Director sold 11,625 shares at $10.06 ($116,995)
  5. 4 Shares withheld for taxes President and CEO gave up 8,059 shares (to pay taxes)
  6. 4 Exercise or conversion Executive Vice Chair acquired 11,111 shares (option exercise)
  7. 4 Exercise or conversion Director acquired 2,000 shares (option exercise)
  8. 4 Exercise or conversion Director acquired 2,000 shares (option exercise)
  9. 4 Planned sale Director sold 11,625 shares at $10.30 ($119,705)
  10. 4 Shares withheld for taxes Chief Financial Officer gave up 3,627 shares (to pay taxes)
  11. 4 Planned sale Director sold 11,625 shares at $12.65 ($147,045)
  12. 4 Open-market buy 10% owner bought 850,000 shares at an average $11.86 ($10,081,721)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market buy 10% owner bought 581,765 shares at an average $18.03 ($10,489,446)
  15. 4 Shares withheld for taxes Chief Medical Officer gave up 25,546 shares (to pay taxes)
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Gift President and CEO gave 2,500 shares (gift)
  19. 4 Gift President and CEO gave 20,000 shares (gift)
  20. 4 Shares withheld for taxes Executive Vice Chair gave up 14,943 shares (to pay taxes)

Page 4 of 23 · 459 filings